New Clinical Trial Reporting Bill Risks Spooking Investors
A new bill aimed at broadening the amount of clinical trial data available on the government's public database would expose early data to drug and device sponsors' investors and competitors, potentially...To view the full article, register now.
Already a subscriber? Click here to view full article